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Abstract
Background: The most widespread method for the treatment of donor milk is the Holder pasteurization (HoP).
The available literature data show that HoP may cause degradation of some bioactive components. The aim of this
study was to determine the effect of HoP on the protein profile of human milk (HM) using a GeLC-MS method, a
proteomic approach and a promising technique able to offer a qualitative HM protein profile.
Methods: HM samples were collected by standardized methods from 20 mothers carrying both preterm and term
newborns. A aliquot of each sample was immediately frozen at -80 °C, whilst another one was Holder pasteurized
and then frozen. All samples were then analyzed by GeLC-MS. The protein bands of interest were excised from the
gel, digested with trypsin and identified by nano-HPLC-MS/MS analysis.
Results: The protein profile before and after HoP showed qualitative differences only in 6 samples out of 20,
while in the remaining 14 no detectable differences were found. The differences interested only colostrums and
transitional milk samples and regarded the decrease of the electrophoretic bands corresponding to alpha and
beta-casein, tenascin, lactoferrin and immunoglobulin.
Conclusions: In the majority of samples, HoP did not cause any modification, thereby preserving the biological
activity of HM proteins.
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Background
Human milk (HM) is considered the “gold standard”
nutrition for feeding term and pre-term newborns [1].
When mother’s own milk is not available or not
sufficient, despite significant lactation support, Donor
Human Milk (DM) is an important and the first alterna-
tive, especially in high risk newborns admitted to Neonatal
Intensive Care Units (NICU) [2, 3].
The main benefit deriving from the use of DM versus
formula milks, in preterm infant feeding, is the reduction
in the incidence of necrotizing enterocolitis (NEC) as
shown by several meta-analysis [4–7]. Moreover, an
enhanced feeding tolerance has also been reported [3, 8].
The DM must be collected, processed and stored
ensuring its microbiological safety maintaining at the
same time the nutritional quality (NQ) [9]. NQ control
of HM storage is complex as well as mandatory and
pasteurization procedure is the main processing step to
inactivate pathogenic microorganisms [2, 10].
DM is typically pasteurized by Holder Pasteurization
method (HoP) characterized by heating at 62.5 °C for
30 min. HoP is currently the requested procedure by
the majority of Human Milk Banking Associations
(HMBA), being a temperature below 62,5 °C considered
not safe [2, 10].
The impact of HoP on the biological quality of HM
has been investigated and results are still controversial
and matter of debate. The main explanations reside in
the different procedures regarding samples collection,
storage and treatment [11–13]. In this regard, data on
the total protein count and specific proteins have been
provided by using immune-enzymatic techniques such
as ELISA. Recently, GeLC-MS, a proteomic approach
involving the separation of proteins in SDS-PAGE by
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one-dimensional electrophoresis (1DE) followed by identi-
fication by mass spectrometry (MS), has been suggested
as a promising technique able to offer a qualitative HM
protein profile [14]. Data on GeLC-MS pattern in HM
previously treated by HoP and later on stored at Human
Milk Bank (HMB) are still lacking.
Therefore, the purpose of the present study was to
determine the effect of HoP on the protein profile of HM
by using GeLC-MS analysis, under reducing and non-
reducing conditions, in order to investigate the qualitative
HM protein profile and the occurrence of protein aggre-
gates, eventually formed after heat treatment.
Methods
Sample collection
We conducted a pretest–test design, where HM samples
acted as their own controls. Breast milk was collected, at
different stage of maturation (colostrum: n = 9; transi-
tional milk: n = 5; mature milk: n = 6) according to
Playford et al. [15], from 20 mothers delivered between
23 and 41 weeks of gestational age (GA). The study was
approved by local ethic committee and mother gave
informed and signed consent to the study.
Exclusion criteria were: maternal infections, tobacco
smokers, drugs addiction and alcoholic; use of drugs or
pharmacologically active substances; mothers who
received blood transfusions or blood products, or organ
transplants; fetal malformations, chromosomal abnor-
malities, perinatal asphyxia and dystocia.
HM samples were collected at two consecutive morn-
ings, between 8 and 9 a.m., into disposable high density
polyethylene sealed bottles (Flormed, Napoli, Italy)
sterilized by using ethylene oxide. Milk expression was
obtained by emptying one or two breasts with an electric
breast pump (Medela Symphony). From each container,
10 mL of HM were taken, divided into two fractions: the
first was immediately frozen at − 80 °C; the second was
pasteurized in HMB and frozen at − 80 °C. HoP was
performed with a Sterifeed Pasteuriser by Medicare Col-
gate Ltd (Cullompton, England), heating milk at 62.5 °C
for 30 min. The last HoP phase requires a rapid and
precise cooling of milk samples to 10 °C in approxi-
mately 20 min, by immersion into cold water.
Sample preparation and protein quantification
Skimmed HM samples were obtained by centrifugation
at 2000 × g for 30 min at 10 °C, the pellet and the float-
ing layer were discarded. Protein content was estimated
according to Bradford [16].
GeLC-MS analysis and protein identification
Skimmed milk samples were mixed with Laemmli buffer
(2 % w/v SDS, 10 % Glycerol, 5 % β-mercaptoethanol, 62
mM Tris-HCl pH 6.8), boiled for 5 min, and loaded on
10 × 8 cm vertical 12 % polyacrylamide gels. For non-
reducing conditions the Laemmli buffer did not contain
β-mercaptoethanol and samples were not boiled.
SDS-PAGE was performed at 10 mA per gel for 30 min
and 30 mA per gel until the tracking dye front reached
the bottom of the gel, at 10 °C with a Mini Protean II Xi
System (Bio-Rad). The running buffer was 25 mM Tris-
HCl, 200 mM Glycine, 0.1 % w/v SDS. The gels were
stained overnight with Colloidal Coomassie brilliant blue
G250 (Bio-Rad Laboratories) in accordance with Neuhoff
et al. [17]. The Coomassie-stained gels were scanned using
an Image Scanner III (GE Healthcare) at 300 dpi. The pro-
tein bands of interest were manually excised from 1DE
gels and in-gel digested with trypsin as described by
Spertino et al. [18]. The peptide mixtures were pooled and
lyophilized in a SpeedVac for mass spectrometry analysis.
MS/MS analysis was performed using a QSTAR XL
hybrid quadrupole-TOF instrument (Applied Biosystems,
Foster City, CA, USA) coupled with a LC Packings
Ultimate 3000 nano-flow LC system (Dionex, Amsterdam,
The Netherlands), as described by Bona et al. [19]. Briefly,
the QSTAR XL operated in positive mode and in
information-dependent acquisition (IDA) mode, the
dynamic exclusion feature of the Analyst QS 1.1 software
(Applied Biosystems, Foster City, CA, USA) was enabled,
with an exclusion mass width of +/−3 m/z for 60 s. LC/
MS-MS files obtained from each protein sample were
merged into a single MASCOT generic format (mgf) file
and searched against the NCBI non-redundant database;
tolerance for precursor and fragment masses was 0.25 Da.
The proteins were identified in homology with significant
ion scores (p < 0.05).
Statistical analysis
Clinical data are reported as the mean and SD. Protein
content (mg/mL) are reported as median and interquartile
ranges. Statistical analysis was performed using XLStat-
Pro v.7.2.5 (Addinsoft, New York, USA). Results were
compared between groups by Mann-Whitney U-two sided
test when the data did not follow a Gaussian distribution.
A value of P < 0.05 was considered significant.
Results
Demographic characteristics of milk donors
The demographic characteristics of the milk donors are
shown in Table 1. As expected, the incidence of delivery
mode and the need of caesarean section were within the
reference for our country. Gestational age and maternal
age at birth were within reference curve for our national
standards. All mothers showed normal clinical conditions.
No overt neurological injury and/or infections were
observed at the sampling time-points or at discharge from
the hospital.
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Total protein content determination
The data of protein content are reported in No-Holder
pasteurized (NO-HoP) and Holder pasteurized (HoP)
groups in Tables 2 and 3. Both in NO-HoP than in HoP
groups no significant differences (P > 0.05, for all) have
been found in total protein content, also after correction
for milk maturity degree (Table 2).
Proteomic analysis and protein identification
The separation of proteins using 1DE permits to
visualize the various protein species in a biological sample;
Fig. 1 shows electrophoretic separation of milk’s proteins,
under reducing and non-reducing conditions.
Six out of 20 samples, corresponding to colostrum (n = 5)
and transitional milk (n = 1), showed a reduction of band
intensity whilst no changes were observed in the mature
Table 1 Demographic characteristics of milk donors
Donor Mother’s ethnic group Age (yrs) Previous breastfeeding GA (wks) Delivery mode Milk maturity degree Spontaneous pregnancy
1 Caucasian 38 Yes 28 CS Mature Yes
2 Caucasian 31 Yes 25 V Transitional Yes
3 Caucasian 38 Yes 35 C Transitional Yes
4 Caucasian 35 Yes 31 CS Mature Yes
5 Caucasian 35 No 23 CS Mature No
6 Caucasian 39 No 35 V Transitional Yes
7 Caucasian 37 No 27 V Transitional Yes
8 Caucasian 25 No 29 CS Mature Yes
9 Caucasian 31 Yes 32 CS Mature Yes
10 Caucasian 33 No 33 CS Transitional Yes
11 Caucasian 30 No 31 CS Mature No
12 Caucasian 22 No 38 V Colostrum Yes
13 Other 33 Yes 40 V Colostrum Yes
14 Caucasian 28 No 38 V Colostrum Yes
15 Caucasian 34 No 39 CS Colostrum Yes
16 Caucasian 40 Yes 38 V Colostrum Yes
17 Caucasian 39 Yes 37 V Colostrum Yes
18 Caucasian 36 No 37 V Colostrum Yes
19 Caucasian 37 Yes 37 V Colostrum Yes
20 Caucasian 33 No 41 V Colostrum Yes
Abbreviations: yrs Years, wks weeks, CS caesarean section, V vaginal
Table 2 The median of protein content in human milk samples
before (No-HoP) and after Holder pasteurization (HoP)
Parameters No-HoP HoP
Median 25 % 75 % Median 25 % 75 %
All milk samples (n = 20) 14.49 10.28 17.22 11.96 10.21 15.65
Colostrum (n = 9) 14.58 13.69 20.32 12.22 11.32 17.72
Transitional (n = 5) 14.89 10.42 16.76 14.50 10.63 15.52
Mature (n = 6) 11.30 8.91 16.71 9.96 8.35 12.00
Data are given in median and interquartile ranges
Table 3 Protein content (mg/ml) in human milk samples before
(No-HoP) and after Holder pasteurization (HoP)
Sample No- HoP HoP
1 12,99 10,16
2 9,99 10,76
3 17,85 14,50
4 8,92 12,00
5 8,02 7,62
6 14,89 15,39
7 10,57 10,27
8 16,71 8,36
9 29,10 30,13
10 16,40 15,92
11 9,63 9,77
12 29,42 21,87
13 13,09 7,82
14 14,59 11,11
15 13,89 12,23
16 14,41 11,92
17 16,29 15,14
18 28,05 31,86
19 9,83 11,40
20 17,74 16,34
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milk samples. There were no differences in the six
samples after correction for delivery mode and/or
gestational age at birth. Reduction of intensity was
observed in three regions: <20 kDA; 25-30 kDa; >250
kDa. Concerning the bands in the region between 25 and
30 kDa, the distribution of aggregates between protein
fragments was altered by pasteurization in five milk
samples, individually or in association with other modifi-
cations. The proteins identified by MS in the different
regions (Fig. 2), are shown in Table 4.
Discussion
When mother’s own milk is not sufficient, donor milk is
the first best choice for feeding term and preterm
newborns, due to its well-recognized nutritional advan-
tages with respect to formula milk [4–8]. DM should be
obtained from established HMBs that follow specific
guidelines for screening, storage, and handling proce-
dures to optimize its composition while ensuring its
safety for the recipient. [2, 10] All the milk arriving to
the Human Milk Bank must be pasteurized. The ideal
pasteurization process should consist of a phase of rapid
heating followed by a phase of constant maintenance of
the temperature and a final phase of rapid cooling.
Pasteurization of the milk minimizes the risk of disease
transmission via HM, inactivating most of the viral and
bacterial contaminants. In addition, donors are screened
in a similar way as for blood donation. No report has
been published showing transfer of diseases through pas-
teurized DM, although milk may contain microorganisms.
[2, 10]. Currently Holder Pasteurization (62.5 °C for
30 min) is the gold standard for milk processing in
Human Milk Banks and is recommended by several
guidelines as the optimal compromise between quality
and microbiological safety [2, 10]. Several studies have
already been performed to evaluate the effects of
pasteurization on mother’s milk macronutrients; the
related results are often discordant, especially con-
cerning proteins [8, 20–22].
Our study observed a non-significant reduction of the
total protein count following HoP of milk samples. This
result is in line with the available literature: several studies
reached similar conclusions using different analytical
methods [20, 21]. Only Vieira et al. in 2011 found
that there was a significant reduction in the mean
protein concentrations, between the raw and post-
pasteurization samples (reduction of 3.9 %). However,
Fig. 1 Representative 1DE profiles of pasteurized milks. Legend. Sample A: milk unchanged after Holder pasteurization; sample B: milk changed
after Holder pasteurization. For each sample, lane 1: raw milk under non-reducing conditions; lane 2: raw milk under reducing conditions; lane
3: pasteurized milk under non-reducing conditions; lane 4: pasteurized milk under reducing conditions. Differences in band profiles were observed
in three molecular weight regions, indicated by the squares
Fig. 2 1DE detail of changed protein bands in the different molecular
weight regions. Legend. Numbers indicate the protein bands identified
by MS/MS analysis
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Table 4 List of proteins identified from bands showing changes after Holder pasteurization
Band no. Protein ID AC number
(gi NCBI)
Theoretical
Mr (kDa)
MASCOT
score
Sequence
coverage (%)
MS/MS sequencing
1 TNC variant protein 68533131 244.2 1177 15 % R.LEELENLVSSLR.E
K.FTTDLDSPR.D
R.ELEPGVEYFIR.V
R.VFAILENKK.S
R.VATYLPAPEGLK.F
R.QTGLAPGQEYEISLHIVK.N
R.LDAPSQIEVK.D
K.ETFTTGLDAPR.N
R.VSQTDNSITLEWR.N
K.TTLTGLRPGTEYGIGVSAVK.E
K.EDKESNPATINAATELDTPK.D
K.ESNPATINAATELDTPK.D
R.GLEPGQEYNVLLTAEK.G
K.AATPYTVSIYGVIQGYR.T
R.AVDIPGLEAATPYR.V
R.TPVLSAEASTAK.E
K.QSEPLEITLLAPER.T
R.EATEYEIELYGISK.G
R.APTAQVESFR.I
K.FTTDLDSPR.D
R.DLTATEVQSETALLTWRPPR.A
K.EVIVGPDTTSYSLADLSPSTHYTAK.I
K.IQALNGPLR.S
R.EEFWLGLDNLNK.I
K.ITAQGQYELR.V
R.DHGETAFAVYDKFSVGDAK.T
2 Beta-casein 288098 25.2 63 12 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
3 Beta-casein 288098 25.2 65 12 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
4 Lactotransferrin 16198359 78.3 333 8 % R.YYGYTGAFR.C
R.THYYAVAVVK.K
R.SDTSLTWNSVK.G
R.CLAENAGDVAFVK.D
R.RSDTSLTWNSVK.G
K.LRPVAAEVYGTER.Q
Immunoglobulin kappa light
chain VLJ region
21669409 29.8 118 17 % R.TVAAPSVFIFPPSDEQLK.S
K.DSTYSLSSTLTLSK.A
K.VYACEVTHQGLSSPVTK.S
Beta-casein 288098 25.2 106 28 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
R.AVPVQALLLNQELLLNPTHQIYPVTQPLAPVHNPISV.-
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these samples were only analyzed with the use of a
FT-IR infrared analyzer [22].
The original contribution of our study consists of the
use of a semi-quantitative analytical method, GeLC-MS
analysis. This technique allows to evaluate the protein
profile of human milk, which is constituted by a com-
plex array of biologically active proteins. Each sample
was tested and compared under reducing and nonreduc-
ing conditions, to highlight the possible presence of
protein-complexes due to disulfide bond formation in
the pasteurization step. However this method is not able
to evaluate the protein changes associated whit inter-
action between proteins and sugars, or proteins and lipid
due to thermic treatments. No differences were observed
between the electrophoretic profile of the same sample
under reducing and nonreducing conditions, except for
the region of high molecular weight, probably corre-
sponding to the formation of high-mass complexes
which do not run in the gel. Over 75 kDa, we observed
more numerous and well separated bands under redu-
cing conditions. The peculiarity in our data consists of
the observation that no variation is present in 14 out of
20 samples (previous studies have detected a variation in
all samples). It is also noteworthy that amongst the 6
samples presenting a modification in the protein levels,
5 derived from colostrum milk and only 1 from transi-
tional milk. This finding is relevant from a clinical prac-
tice standpoint, since donor milk usually consists of
Table 4 List of proteins identified from bands showing changes after Holder pasteurization (Continued)
Immunoglobulin lambda
light chain
33700 25.2 77 20 % R.SYSCQVTHEGSTVEK.T
K.YAASSYLSLTPEQWK.S
K.AAPSVTLFPPSSEELQANK.A
5 Immunoglobulin kappa light
chain VLJ region
21669357 29.5 381 34 % K.LLIYWASTR.E
K.DSTYSLSSTLTLSK.A
K.SGTASVVCLLNNFYPR.E
K.LYACEVTHQGLSSPVTK.S
R.TVAAPSVFIFPPSDEQLK.S
K.VDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSK.A
Alpha S1-casein 1359714 20.7 192 19 % R.LQNPSESSEPIPLESR.E
R.LNEYNQLQLQAAHAQEQIR.R
Immunoglobulin lambda
light chain
33700 25.2 139 14 % K.YAASSYLSLTPEQWK.S
K.AAPSVTLFPPSSEELQANK.A
Beta-casein precursor 4503087 25.4 115 11 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
6 Beta-casein 288098 25.2 49 12 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
7 Alpha S1-casein 1359714 20.7 56 10 % R.LNEYNQLQLQAAHAQEQIR.R
Beta-casein 288098 25.2 50 12 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
8 Beta-casein 288098 25.2 38 12 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
9 Beta-casein 288098 25.2 81 12 % K.SPTIPFFDPQIPK.L
K.VLPIPQQVVPYPQR.A
tenascin 37227 240.6 70 1 % R.LEELENLVSSLR.E
alpha S1-casein 1359714 20.7 65 10 % R.LNEYNQLQLQAAHAQEQIR.R
10 Lactoferrin 186833 78.3 203 3 % R.THYYAVAVVK.K
K.LADFALLCLDGK.R
K.NLLFNDNTECLAR.L
Beta-casein 288098 25.2 38 6 % K.VLPIPQQVVPYPQR.A
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mature milk (which, according to our data, did not show
any variation).
Each band showing a variation was then identified with
the corresponding protein(s). The bands of greatest inter-
est are the ones of medium molecular weight (25–30 kDa)
since they contain beta casein, alpha-casein, lactoferrin
fragments and immunoglobulin light chains (Igκ and Igλ);
the other band of interest (250 kDa) was identified as
tenascin.
Tenascin is a homohexameric disulfide-linked glyco-
protein and its expression decreases with lactation. This
protein was investigated in recent studies for its
antimicrobial properties in milk and Fouda et al. have
hypothesized its ability to neutralize the HIV-1 virus via
binding to the chemokine receptor site [23]. Tenascin
has never been evaluated previously in human milk after
pasteurization and we observed a reduction only in
reduced samples of colostrum.
Beta-casein and alpha-casein are two important proteins
of human milk. Only one previous study has investigated
the effect of Holder pasteurization on these proteins using
an electrophoretic analysis method and has shown a slight
decrease in a single pooled sample [14].
IgA antibodies in breast milk provide passive immunity
and sufficient protection against infections to neonates
and preterm infants [24]. Lactoferrin is a bioactive protein
that serves as an immunomodulatory factor [24]. Several
studies revealed a number of functions of these molecules:
i) IgA has specific antigen-targeted anti-infective action; ii)
lactoferrin plays important roles in immunomodulation,
iron chelation and antimicrobial action, and exhibits the
anti-adhesive and trophic properties necessary for intes-
tinal growth [24, 25]. Overall, regarding lactoferrin and
IgA, our study is partially in agreement with the results
reported in the literature, in which a decrease was found
in all samples tested, in contrast to our findings. There
might be two reasons for these differences: i) we did not
use pooled milk (as done in several previous studies) but
we have analyzed all milk samples individually; further-
more the same samples have been analyzed before and
after pasteurization; ii) we have utilized a GeLC-MS
analysis (semi-quantitative technique), instead of an im-
munohistochemical analytical techniques like the ELISA
test. Additionally, there is a significant variability in previ-
ous studies concerning the retention of these proteins
after HoP, which can be ascribed not only to heterogeneity
in methods of human milk collection but also to treat-
ment and storage before and after HoP [11–13].
Conclusion
In conclusion, donor milk needs a heat treatment for a
safety storage. Holder Pasteurization is the method
recommended by all international guidelines for the
constitutions of Human Milk Banks. Our data are in
agreement with literature showing a small decrease in
the total protein content of human milk after HoP.
Nonetheless, samples obtained from different donors
reacted differently to heat treatment, even if processed
and stored using the same conditions: in particular, 30 %
of the samples showed some differences in the protein
profile after HoP, whereas 70 % of the samples showed
no detectable differences. The detectable effects on the
protein profile were mainly in colostrum samples; this
variation is quite interesting from a clinical standpoint,
since donor milk is mostly constituted by mature milk.
The reasons for this apparent variability is not clear and
would deserve further investigation. In this setting, future
studies should be designed to investigate whether these
differences are also confirmed by other techniques able to
assess the protein changes due to thermic treatments
including the interaction between proteins and sugars, or
proteins and lipid with possible toxic derivatives.
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